This Pharma Company Announced 1:1 Bonus- Record Date: 24/3/2026

Kilitch Drugs Bonus Issue: Kilitch Drugs (India) Ltd has announced a 1:1 bonus issue, with the announcement made on 11 February 2026, the record date fixed for 24 March 2026, and the deemed allotment date scheduled for 25 March 2026. Eligible shareholders will receive one new equity share for every existing share held.

Kilitch Drugs Bonus Issue:

📌 Key Details of the Bonus Issue

• Announcement Date: 11 February 2026

• Bonus Ratio: 1:1 (One bonus share for every existing share)

• Record Date: 24 March 2026

• Ex-Bonus Date: 24 March 2026

• Allotment Date: 25 March 2026

• Face Value of Shares: ₹10 per equity share

🔎 What This Means for Shareholders

• Eligibility: Shareholders whose names appear in the company’s register of members as of 24 March 2026 will be entitled to receive bonus shares.

• Impact on Holdings: If you hold 100 shares of Kilitch Drugs as of the record date, you will receive an additional 100 shares, doubling your total to 200.

• Capital Structure: The bonus issue will increase the number of outstanding shares but will not affect the overall market capitalization, as the share price typically adjusts downward to reflect the increased number of shares.

• Liquidity Boost: The move is expected to improve liquidity in the stock, making it more attractive to retail investors.

Kilitch Drugs Bonus Issue:

📈 Strategic Context

Kilitch Drugs (India) Ltd, a pharmaceutical company known for its formulations and healthcare products, has opted for this bonus issue as part of its shareholder-friendly initiatives. The decision was approved during the Extra-Ordinary General Meeting (EGM) held on 13 March 2026, where shareholders gave their consent to the proposal.

Such corporate actions often signal management’s confidence in the company’s future earnings and growth prospects. By issuing bonus shares, Kilitch Drugs aims to:

• Reward existing shareholders without impacting cash reserves.

• Enhance retail participation by making the stock more affordable post-adjustment.

• Strengthen investor sentiment ahead of potential expansion or new product launches.

✅ Conclusion

The upcoming bonus issue of Kilitch Drugs India Ltd is a significant event for investors, offering a 1:1 share distribution that will double their holdings without additional cost. With the record date on 24 March 2026 and allotment on 25 March 2026, shareholders should ensure their holdings are in place before the ex-bonus date to benefit from this corporate action.

Disclaimer: Investments in Capital Market/Share Prices are subject to market fluctuations and are dependent on several factors. These predictions are based on the current market conditions and the future market expectations. Investors are advised to take into consideration all these factors before making any investment in Capital Market. This article should not be treated as Investment advisory and is for general Guidance & Educational purpose only. We keep revising our share price targets based on the latest information available with us. Please keep visiting our website regularly to keep yourself updated. News4You does not offer investment advice and does not encourage any action based on its content.

Read Also: